Clinical Trial Detail

NCT ID NCT03123978
Title Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

prostate cancer

Therapies

Enzalutamide + Niclosamide

Age Groups: adult senior

No variant requirements are available.